123 related articles for article (PubMed ID: 38359097)
1. Correction to: Macromolecular Complex Including MLL3, Carabin and Calcineurin Regulates Cardiac Remodeling.
Circ Res; 2024 Feb; 134(4):e2. PubMed ID: 38359097
[No Abstract] [Full Text] [Related]
2. Macromolecular Complex Including MLL3, Carabin and Calcineurin Regulates Cardiac Remodeling.
Pane R; Laib L; Formoso K; Détrait M; Sainte-Marie Y; Bourgailh F; Ruffenach N; Faugeras H; Simon I; Lhuillier E; Lezoualc'h F; Conte C
Circ Res; 2024 Jan; 134(1):100-113. PubMed ID: 38084599
[TBL] [Abstract][Full Text] [Related]
3. Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+/calmodulin-dependent protein kinase II signaling.
Bisserier M; Berthouze-Duquesnes M; Breckler M; Tortosa F; Fazal L; de Régibus A; Laurent AC; Varin A; Lucas A; Branchereau M; Marck P; Schickel JN; Deloménie C; Cazorla O; Soulas-Sprauel P; Crozatier B; Morel E; Heymes C; Lezoualc'h F
Circulation; 2015 Jan; 131(4):390-400; discussion 400. PubMed ID: 25369805
[TBL] [Abstract][Full Text] [Related]
4. Feedback inhibition of calcineurin and Ras by a dual inhibitory protein Carabin.
Pan F; Sun L; Kardian DB; Whartenby KA; Pardoll DM; Liu JO
Nature; 2007 Jan; 445(7126):433-6. PubMed ID: 17230191
[TBL] [Abstract][Full Text] [Related]
5. Carabin Deficiency Aggravates Hepatic Ischemia-Reperfusion Injury Through Promoting Neutrophil Trafficking
Ni X; Wu X; Zhu XX; Li JH; Yin XY; Lu L
Front Immunol; 2022; 13():773291. PubMed ID: 35265067
[TBL] [Abstract][Full Text] [Related]
6. Carabin: Endogenous calcineurin inhibitor, a potential diagnostic and therapeutic target for cardiac hypertrophy in heart failure.
Yi X; Li X; Jiang X
Int J Cardiol; 2016 Jun; 212():57-8. PubMed ID: 27031820
[No Abstract] [Full Text] [Related]
7. [Molecular determinants of pathological cardiac remodeling: the examples of Epac and Carabin].
Sainte-Marie Y; Bisserier M; Tortosa F; Lezoualc'h F
Med Sci (Paris); 2015 Oct; 31(10):881-8. PubMed ID: 26481027
[TBL] [Abstract][Full Text] [Related]
8. MLL3 regulates the
Zhu C; Soto-Feliciano YM; Morris JP; Huang CH; Koche RP; Ho YJ; Banito A; Chen CW; Shroff A; Tian S; Livshits G; Chen CC; Fennell M; Armstrong SA; Allis CD; Tschaharganeh DF; Lowe SW
Elife; 2023 Jun; 12():. PubMed ID: 37261974
[TBL] [Abstract][Full Text] [Related]
9. CARM1-mediated methylation of ASXL2 impairs tumor-suppressive function of MLL3/COMPASS.
Zhao Z; Rendleman EJ; Szczepanski AP; Morgan MA; Wang L; Shilatifard A
Sci Adv; 2022 Oct; 8(40):eadd3339. PubMed ID: 36197977
[TBL] [Abstract][Full Text] [Related]
10. Requirement for MLL3 in p53 regulation of hepatic expression of small heterodimer partner and bile acid homeostasis.
Kim DH; Kim J; Lee JW
Mol Endocrinol; 2011 Dec; 25(12):2076-83. PubMed ID: 22034226
[TBL] [Abstract][Full Text] [Related]
11. Effects of the calcineurin dependent signaling pathway inhibition by cyclosporin A on early and late cardiac remodeling following myocardial infarction.
Youn TJ; Piao H; Kwon JS; Choi SY; Kim HS; Park DG; Kim DW; Kim YG; Cho MC
Eur J Heart Fail; 2002 Dec; 4(6):713-8. PubMed ID: 12453541
[TBL] [Abstract][Full Text] [Related]
12. Cardiac CaM Kinase II genes δ and γ contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophy.
Kreusser MM; Lehmann LH; Keranov S; Hoting MO; Oehl U; Kohlhaas M; Reil JC; Neumann K; Schneider MD; Hill JA; Dobrev D; Maack C; Maier LS; Gröne HJ; Katus HA; Olson EN; Backs J
Circulation; 2014 Oct; 130(15):1262-73. PubMed ID: 25124496
[TBL] [Abstract][Full Text] [Related]
13. Reversibility of adverse, calcineurin-dependent cardiac remodeling.
Berry JM; Le V; Rotter D; Battiprolu PK; Grinsfelder B; Tannous P; Burchfield JS; Czubryt M; Backs J; Olson EN; Rothermel BA; Hill JA
Circ Res; 2011 Aug; 109(4):407-17. PubMed ID: 21700928
[TBL] [Abstract][Full Text] [Related]
14. Prolyl 4-hydroxylase 2 promotes B-cell lymphoma progression via hydroxylation of Carabin.
Jiang W; Zhou X; Li Z; Liu K; Wang W; Tan R; Cong X; Shan J; Zhan Y; Cui Z; Jiang L; Li Q; Shen S; Bai M; Cheng Y; Li B; Tan M; Ma DK; Liu JO; Dang Y
Blood; 2018 Mar; 131(12):1325-1336. PubMed ID: 29437589
[TBL] [Abstract][Full Text] [Related]
15. Calcineurin and electrical remodeling in pathologic cardiac hypertrophy.
Liu HB; Yang BF; Dong DL
Trends Cardiovasc Med; 2010 Jul; 20(5):148-53. PubMed ID: 21742270
[TBL] [Abstract][Full Text] [Related]
16. The MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers.
Hu D; Gao X; Morgan MA; Herz HM; Smith ER; Shilatifard A
Mol Cell Biol; 2013 Dec; 33(23):4745-54. PubMed ID: 24081332
[TBL] [Abstract][Full Text] [Related]
17. Calcineurin-NFATc regulates type 2 inositol 1,4,5-trisphosphate receptor (InsP3R2) expression during cardiac remodeling.
Sankar N; deTombe PP; Mignery GA
J Biol Chem; 2014 Feb; 289(9):6188-98. PubMed ID: 24415751
[TBL] [Abstract][Full Text] [Related]
18. Cullin-associated and neddylation-dissociated 1 protein (CAND1) governs cardiac hypertrophy and heart failure partially through regulating calcineurin degradation.
Li X; Zhang Y; Zhao Y; Zhou Y; Han Q; Yang Y; Zhang L; Shi L; Jin X; Zhang R; Gao H; Xue G; Li D; Zhang ZR; Lu Y; Yang B; Pan Z
Pharmacol Res; 2022 Aug; 182():106284. PubMed ID: 35661710
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy.
Dong DL; Chen C; Huo R; Wang N; Li Z; Tu YJ; Hu JT; Chu X; Huang W; Yang BF
Hypertension; 2010 Apr; 55(4):946-52. PubMed ID: 20177001
[TBL] [Abstract][Full Text] [Related]
20. Unique Role of the WD-40 Repeat Protein 5 (WDR5) Subunit within the Mixed Lineage Leukemia 3 (MLL3) Histone Methyltransferase Complex.
Shinsky SA; Cosgrove MS
J Biol Chem; 2015 Oct; 290(43):25819-33. PubMed ID: 26324722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
